First non-peptide oral GLP-1 for chronic weight management No injections required No fasting or food restrictions Demonstrated ~12.4% weight loss in Phase 3 trials This innovation has the potential to improve patient acceptance and adherence, making evidence-based obesity treatment more accessible than ever
With daily lessons rooted in psychology and biology, expert coaching, and cutting-edge AI support, Noom meets you where you areand helps you get where you want to go
Eduvest, 2 (8), 2775-3727
Nat Rev Immunol (2003) 3(7):52133.10.1038/nri1132 10 NeurathMFFinottoSGlimcherLH
max ( Phaseolus vulgaris (Loscos et al., 2008)
However, the reduction in WOMAC pain scores was significantly greater in the peptide group compared with both PRP and HA